TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biorecro AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
286
|
273
|
206 |
| Financial expenses |
22
|
56
|
0 |
| Earnings before taxes |
7
|
-95
|
-5 |
| EBITDA |
27
|
-39
|
-5 |
| Total assets |
344
|
228
|
171 |
| Current assets |
33
|
228
|
171 |
| Current liabilities |
213
|
153
|
96 |
| Equity capital |
10
|
3
|
75 |
| - share capital |
5
|
5
|
5 |
| Employees (average) |
4
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
2.9%
|
1.3%
|
43.9% |
| Turnover per employee |
72
|
91
|
69 |
| Profit as a percentage of turnover |
2.4%
|
-34.8%
|
-2.4% |
| Return on assets (ROA) |
8.4%
|
-17.1%
|
-2.9% |
| Current ratio |
15.5%
|
149.0%
|
178.1% |
| Return on equity (ROE) |
70.0%
|
-3166.7%
|
-6.7% |
| Change turnover |
12
|
84
|
14 |
| Change turnover % |
4%
|
44%
|
7% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
33%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.